A recent commentary (Stavra A. Xanthakos and Jeffrey B. Schwimmer. Nat Rev Gastroenterol Hepatol. 2015 Jun; 12(6): 316–318.) discusses the role of bariatric surgery for teenagers with severe nonalcoholic fatty liver disease (NAFLD). Full text Link: On a knife-edge—weight-loss surgery for NAFLD in adolescents.
Here’s an excerpt:
Abstract: A new position statement from Europe endorses expert-based recommendations to consider bariatric surgery as a treatment for severe NAFLD in severely obese adolescents. This article discusses the problem of severe paediatric obesity, its relationship with NAFLD, and the knowledge and needs regarding bariatric surgery in adolescents… it is critical that adolescents with NAFLD undergoing bariatric surgery be evaluated and managed in bariatric surgery centres with appropriate paediatric multidisciplinary expertise and a commitment to rigorously phenotype NAFLD histology at baseline and to follow outcomes prospectively as long as possible. These procedures can be particularly challenging in adolescents, who are prone to relocate in adulthood and thus might not return for follow-up. High quality prospective multicentre studies with low attrition rates, such as the Teen Longitudinal Assessment of Bariatric Surgery (USA) and the Adolescent Morbid Obesity Study (Sweden) have begun to provide short to intermediate term (1–2 year) outcomes after adolescent bariatric surgery, but do not include prospectively collected data on histological liver outcomes to support evidence-based recommendations regarding NASH as a specific indication for bariatric surgery. However, given the benefits that are emerging for type 2 diabetes and sleep apnoea, (which are comorbid conditions often associated with NASH), we concur with previously published expert guidelines that conclude that bariatric surgery is not contraindicated in a non-cirrhotic patient with NAFLD who otherwise meets appropriate medical and psychosocial criteria for bariatric surgery.2 The adolescent and family should, however, be counselled that a positive outcome with respect to NAFLD is, as yet, not a foregone conclusion.
Related blog posts:

Pingback: NAFLD Outcomes After Bariatric Surgery | gutsandgrowth
Pingback: Risk Factors for Progressive, Fibrotic Fatty Liver Disease | gutsandgrowth
Pingback: Improving Fatty Liver Disease Nomenclature | gutsandgrowth
Pingback: Bad Fatty Liver Disease Can Get Worse Quickly | gutsandgrowth
Pingback: Fatty Liver Feast (of Articles): NAFLD 2020 | gutsandgrowth
Pingback: Online Aspen Webinar (Part 6) -NAFLD and NASH | gutsandgrowth
Pingback: Progression of Fatty Liver Disease in Children | gutsandgrowth
Pingback: Best Practice for Fatty Liver Disease | gutsandgrowth
Pingback: Is Fatty Liver Increased in Pediatric Population with Type 1 Diabetes Mellitus? | gutsandgrowth
Pingback: Why It Is Hard to Stop Immunosuppression with Autoimmune Hepatitis and Lower Bone Density with Fatty Livers | gutsandgrowth
Pingback: Losartan: Not Effective for Pediatric NAFLD | gutsandgrowth